2017
DOI: 10.3389/fimmu.2017.00214
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-4 Inhibits Regulatory T Cell Differentiation through Regulating CD103+ Dendritic Cells

Abstract: CD103+ dendritic cells (DCs) have been shown to play a crucial role in the pathogenesis of inflammatory bowel diseases (IBDs) through educating regulatory T (Treg) cells differentiation. However, the mechanism of CD103+ DCs subsets differentiation remains elusive. Interleukin (IL)-4 is a pleiotropic cytokine that is upregulated in certain types of inflammation, including IBDs and especially ulcerative colitis. However, the precise role of IL-4 in the differentiation of CD103+ DCs subpopulation remains unknown.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 49 publications
0
24
0
Order By: Relevance
“…Since type I IFN is primarily produced by plasmacytoid dendritic cells (pDC), we selected dendritic cell-related genes or type I IFN-related genes with significant biological implications for quantification using RT-qPCR among the 218 genes as follows: BATF2, LAMP3, and CD83 are related to dendritic cell activation and maturation [17][18][19]; TNFSF10, BTLA, and IDO1 are expressed on dendritic cells (DCs) [20][21][22][23][24]. CLEC4A has a role in the production of type I IFN from pDC [25], and STAT1, STAT2, and IRF7 have roles in the signal of type I IFN production [26][27][28].…”
Section: Other Treatment Response-associated Molecules Confirmed By Rmentioning
confidence: 99%
“…Since type I IFN is primarily produced by plasmacytoid dendritic cells (pDC), we selected dendritic cell-related genes or type I IFN-related genes with significant biological implications for quantification using RT-qPCR among the 218 genes as follows: BATF2, LAMP3, and CD83 are related to dendritic cell activation and maturation [17][18][19]; TNFSF10, BTLA, and IDO1 are expressed on dendritic cells (DCs) [20][21][22][23][24]. CLEC4A has a role in the production of type I IFN from pDC [25], and STAT1, STAT2, and IRF7 have roles in the signal of type I IFN production [26][27][28].…”
Section: Other Treatment Response-associated Molecules Confirmed By Rmentioning
confidence: 99%
“…Interestingly, ILC2 in both mesenteric lymph nodes and the peritoneal lavage increase in H. polygyrus infections also expand and activate the host's T reg population, especially early in an infection when these cells appear to outpace the proliferation of effector T cells and modulate the immune response (Filbey, Grainger et al, 2014). An increased frequency of T reg -possibly as a result of low dose IL-4 exposure (Tu, Chen et al, 2017) was observed in the mesenteric lymph nodes of infected CCT8 T-/animals where these cells may further inhibit Th2 immunity (Grainger, Smith et al, 2010). However, the frequency of T reg was significantly reduced in the peritoneal lavage.…”
Section: Discussionmentioning
confidence: 99%
“…Upon re-infection with H. polygyrus, the ILC2 frequency was comparable for CCT8 T-/and CCT8 T+/+ mice but the absolute cellularity was lower in mutant mice (Figure 5h). This finding correlated with a lack of intestinal tuft cells, thus suggesting a feed-forward loop which increases numbers of these cells (Gerbe, Sidot et al, 2016, von Moltke et al, 2016 whereby ILC2 cells do not suffice and an adaptive T cell contribution is required. This is, however, absent in the CCT8 T+/+ mice, particularly during a secondary infection (Figure EV 4).…”
Section: Cct8 Is Essential For Protective Immunity Against Intestinalmentioning
confidence: 94%
See 1 more Smart Citation
“…Although increased IL-4 may initially constitute a protective response (by regulating M1 and Th1 activation), this Th2 cytokine also exhibits more detrimental effects. For example, in vitro studies show that IL-4 may diminish IDO expression in dendritic cells (Tu et al, 2017) (thereby decreasing the protective CIRS effects of the TRYCAT pathway), reduce dendritic cell expression of IL-10 thereby promoting a Th1 phenotype and inhibiting Treg cell differentiation (Yao et al, 2005;Tu et al, 2017). This may explain that IL-4 is involved in certain types of inflammatory diseases by orchestrating the functional phenotype of dendritic cells (Tu et al, 2017).…”
Section: -Comparison Of the Baseline Biomarkers Between Mdd Patientsmentioning
confidence: 99%